For more than 55 years, Bruker has enabled scientists to make breakthrough discoveries and develop new applications that improve the quality of human life. Bruker’s high-performance scientific instruments and high-value analytical and diagnostic solutions enable scientists to explore life and materials at molecular, cellular and microscopic levels.
In close cooperation with our customers, Bruker is enabling innovation, productivity and customer success in life science molecular research, in applied and pharma applications, and in microscopy, nano-analysis and industrial applications. In recent years, Bruker has also become a provider of high-performance systems for cell biology, preclinical imaging, clinical phenomics and proteomics research, clinical microbiology, and for molecular pathology research.
HTX Technologies ofers innovative sample preparation systems for advanced analytical platforms. Our integrated workflow solutions include user training, instrumentation, software, consumables and method development services.
ImaBiotech is a contract research organization (CRO) that offers services in mass spectrometry imaging (MSI); along with developing and implementing new imaging technologies, such as Quantinetix™ and Multimaging™. The main facility is located in Europe (Lille, France), with a new laboratory in North America (Billerica, MA), and a distributor in Asia (Nagoya, Japan). In order to accelerate drug development, ImaBiotech offers Mass Spectrometry Services, such as MALDI high resolution mass spectrometry imaging to provide a cost effective solution to preclinical and clinical studies. This molecular technique is used both qualitatively and quantitatively for understanding the efficacy and toxicity of drug candidates.
New River Labs is the leading provider of mass spectrometry imaging based diagnostic and prognostic tests designed to address unmet clinical needs and improve patient care. Our tests provide physicians with actionable intelligence to develop personalized treatment plans, leading to improved patient outcomes. We use histology-guided mass spectrometry (HGMS) profiling, a proprietary application of mass spectrometry imaging, to target specific cells of interest within tissue sections. By applying machine learning resources to HGMS data, we develop classification algorithms that can differentiate between disease states and treatment responses. We are actively seeking collaborative research partnerships with principal investigators and key opinion leaders to expand our portfolio of MALDI mass spectrometry based clinical assays.
Waters Corporation (NYSE: WAT), the world's leading specialty measurement company, has pioneered chromatography, mass spectrometry and thermal analysis innovations serving the life, materials and food sciences for nearly 60 years. With approximately 7,000 employees worldwide, Waters operates directly in 31 countries, including 15 manufacturing facilities, and with products available in more than 100 countries.